AP Biosciences Inc (TPEX:6945)

AP Biosciences Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	1,361	1,442	278.61	1,048
Short-Term Investments	-	100	461.41	30.71
Cash & Short-Term Investments	1,361	1,542	740.02	1,079
Cash Growth	-21.82%	108.33%	-31.40%	-
Other Receivables	35.61	36.18	24.6	14.48
Receivables	35.61	36.18	24.6	14.48
Prepaid Expenses	6.57	3.63	1.03	0.85
Total Current Assets	1,403	1,581	765.64	1,094
Property, Plant & Equipment	109.07	109.33	116.41	3.02
Other Intangible Assets	3.29	3.55	4.23	5.34
Other Long-Term Assets	3.29	32.8	4.48	0.78
Total Assets	1,549	1,727	890.76	1,103
Accrued Expenses	11.58	22.64	16.72	2.48
Current Portion of Leases	11.65	11.65	11.65	-
Other Current Liabilities	5.09	5.37	2.51	2.04
Total Current Liabilities	28.31	39.67	30.88	4.52
Long-Term Leases	53.59	59.26	70.43	-
Other Long-Term Liabilities	5.51	5.46	5.35	-
Total Liabilities	87.41	104.38	106.65	4.52
Common Stock	851.13	849.87	647.48	647.48
Additional Paid-In Capital	809.02	1,197	475.92	739.72
Retained Earnings	-197.72	-422.75	-339.3	-288.54
Comprehensive Income & Other	-1.33	-1.08	-	-
Shareholders' Equity	1,461	1,623	784.11	1,099
Total Liabilities & Equity	1,549	1,727	890.76	1,103
Total Debt	65.24	70.91	82.08	-
Net Cash (Debt)	1,296	1,471	657.94	1,079
Net Cash Growth	-22.15%	123.54%	-39.01%	-
Net Cash Per Share	15.24	19.53	10.16	20.49
Filing Date Shares Outstanding	85.11	84.99	64.75	56.55
Total Common Shares Outstanding	85.11	84.99	64.75	56.55
Working Capital	1,375	1,542	734.77	1,090
Book Value Per Share	17.17	19.09	12.11	19.43
Tangible Book Value	1,458	1,619	779.88	1,093
Tangible Book Value Per Share	17.13	19.05	12.04	19.33
Machinery	50.82	39.3	36.93	31.34
Construction In Progress	-	-	28.2	-
Leasehold Improvements	35.02	35.5	-	1

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.